Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 357


Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: 12-Month Observational Data From the Randomized Phase III Trial, MODIFY II.

Goldstein EJC, Citron DM, Gerding DN, Wilcox MH, Gabryelski L, Pedley A, Zeng Z, Dorr MB.

Clin Infect Dis. 2019 Dec 23. pii: ciz1151. doi: 10.1093/cid/ciz1151. [Epub ahead of print]


Reply to Barner and Bruno-Murtha.

Kullar R, Nagel J, Bleasdale SC, Sutton SH, Naumovski S, Smith C, Leggett J, Wollins D, Busky C, Goldstein EJC.

Clin Infect Dis. 2019 Sep 23. pii: ciz935. doi: 10.1093/cid/ciz935. [Epub ahead of print] No abstract available.


Whole-Genome Sequencing To Identify Drivers of Carbapenem-Resistant Klebsiella pneumoniae Transmission within and between Regional Long-Term Acute-Care Hospitals.

Han JH, Lapp Z, Bushman F, Lautenbach E, Goldstein EJC, Mattei L, Hofstaedter CE, Kim D, Nachamkin I, Garrigan C, Jain T, Bilker W, Wolford HM, Slayton RB, Wise J, Tolomeo P, Snitkin ES.

Antimicrob Agents Chemother. 2019 Oct 22;63(11). pii: e01622-19. doi: 10.1128/AAC.01622-19. Print 2019 Nov.


The Influence of Microaffirmations on Undergraduate Persistence in Science Career Pathways.

Estrada M, Young GR, Nagy J, Goldstein EJ, Ben-Zeev A, Márquez-Magaña L, Eroy-Reveles A.

CBE Life Sci Educ. 2019 Sep;18(3):ar40. doi: 10.1187/cbe.19-01-0012.


Yellow fever vaccine-associated neurological disease: it is not just the silver generation at risk.

Goldstein EJ, Bell DJ, Gunson RN.

BMJ Case Rep. 2019 May 13;12(5). pii: e229558. doi: 10.1136/bcr-2019-229558.


U.S.-Based National Surveillance for Fidaxomicin Susceptibility of Clostridioides difficile-Associated Diarrheal Isolates from 2013 to 2016.

Thorpe CM, McDermott LA, Tran MK, Chang J, Jenkins SG, Goldstein EJC, Patel R, Forbes BA, Johnson S, Gerding DN, Snydman DR.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00391-19. doi: 10.1128/AAC.00391-19. Print 2019 Jul.


Investigational drug therapies currently in early-stage clinical development for the treatment of clostridioides (clostridium) difficile infection.

Tran MN, Kullar R, Goldstein EJC.

Expert Opin Investig Drugs. 2019 Apr;28(4):323-335. doi: 10.1080/13543784.2019.1581763. Epub 2019 Feb 26. Review.


Choosing an appropriate probiotic product for your patient: An evidence-based practical guide.

Sniffen JC, McFarland LV, Evans CT, Goldstein EJC.

PLoS One. 2018 Dec 26;13(12):e0209205. doi: 10.1371/journal.pone.0209205. eCollection 2018.


In-house validation of the cobas Liat influenza A/B and RSV assay for use with gargles, sputa and endotracheal secretions.

Goldstein EJ, Gunson RN.

J Hosp Infect. 2019 Mar;101(3):289-291. doi: 10.1016/j.jhin.2018.10.025. Epub 2018 Nov 5. No abstract available.


Going for the Gold: A Description of the Centers of Excellence Designation by the Infectious Diseases Society of America.

Kullar R, Nagel J, Bleasdale SC, Sutton SH, Naumovski S, Rodriguez A, Smith C, Leggett J, Goldstein EJC.

Clin Infect Dis. 2019 May 2;68(10):1777-1782. doi: 10.1093/cid/ciy797.


In vitro activity of DS-2969b and comparator antimicrobial agents against Clostridioides (Clostridium) difficile, methicillin-resistant Staphylococcus aureus, and other anaerobic bacteria.

Tyrrell KL, Citron DM, Merriam CV, Leoncio E, Goldstein EJC.

Anaerobe. 2018 Dec;54:39-41. doi: 10.1016/j.anaerobe.2018.04.010. Epub 2018 Apr 13.


In vitro activity of eravacycline and comparator antimicrobials against 143 recent strains of Bacteroides and Parabacteroides species.

Goldstein EJC, Citron DM, Tyrrell KL.

Anaerobe. 2018 Aug;52:122-124. doi: 10.1016/j.anaerobe.2018.06.016. Epub 2018 Jul 4.


Molecular epidemiology of Clostridioides (Clostridium) difficile strains recovered from clinical trials in the US, Canada and Europe from 2006-2009 to 2012-2015.

Cheknis A, Johnson S, Chesnel L, Petrella L, Sambol S, Dale SE, Nary J, Sears P, Citron DM, Goldstein EJC, Gerding DN.

Anaerobe. 2018 Oct;53:38-42. doi: 10.1016/j.anaerobe.2018.05.009. Epub 2018 May 26.


Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis.

McFarland LV, Evans CT, Goldstein EJC.

Front Med (Lausanne). 2018 May 7;5:124. doi: 10.3389/fmed.2018.00124. eCollection 2018.


Comparative In Vitro Activity of Omadacycline against Dog and Cat Bite Wound Isolates.

Goldstein EJC, Citron DM, Tyrrell KL, Leoncio E, Merriam CV.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02551-17. doi: 10.1128/AAC.02551-17. Print 2018 Apr.


Integrating patient and whole-genome sequencing data to provide insights into the epidemiology of seasonal influenza A(H3N2) viruses.

Goldstein EJ, Harvey WT, Wilkie GS, Shepherd SJ, MacLean AR, Murcia PR, Gunson RN.

Microb Genom. 2018 Jan;4(1). doi: 10.1099/mgen.0.000137. Epub 2017 Dec 21.


Comparative In Vitro Activities of Relebactam, Imipenem, the Combination of the Two, and Six Comparator Antimicrobial Agents against 432 Strains of Anaerobic Organisms, Including Imipenem-Resistant Strains.

Goldstein EJC, Citron DM, Tyrrell KL, Leoncio E, Merriam CV.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01992-17. doi: 10.1128/AAC.01992-17. Print 2018 Feb.


Corrigendum: Description of two novel members of the family Erysipelotrichaceae: Ileibacterium valens gen. nov., sp. nov. and Dubosiella newyorkensis, gen. nov., sp. nov., from the murine intestine, and emendation to the description of Faecalibacterium rodentium.

Cox LM, Sohn J, Tyrrell KL, Citron DM, Lawson PA, Patel NB, Iizumi T, Perez-Perez GI, Goldstein EJC, Blaser MJ.

Int J Syst Evol Microbiol. 2017 Oct;67(10):4289. doi: 10.1099/ijsem.0.002339. No abstract available.


In Vitro Activities of Pexiganan and 10 Comparator Antimicrobials against 502 Anaerobic Isolates Recovered from Skin and Skin Structure Infections.

Goldstein EJC, Citron DM, Tyrrell KL, Leoncio ES.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01401-17. doi: 10.1128/AAC.01401-17. Print 2017 Dec.

Supplemental Content

Loading ...
Support Center